Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SIRT6 activation attenuates inflammatory-fibrogenic events, improves lung function and survival in experimental pulmonary fibrosis.

Biochemical pharmacology·2026
Same author

A prospective randomized study of sequential boost versus simultaneous integrated boost intensity-modulated radiation therapy with concurrent chemotherapy in locally advanced head and neck cancer.

Journal of cancer research and therapeutics·2026
Same author

Correction: Parental RNA interference (pRNAi) in insects: mechanisms, applications, and challenges in pest management.

Molecular biology reports·2026
Same author

Listeria Monocytogenes: A Case Series and Clinical Insights from a Tertiary Care Hospital.

Journal of pharmacy & bioallied sciences·2026
Same author

A Prospective Randomized Study to Compare Ultrasound Guided Transversus Abdominis Plane Block and Caudal Epidural Block for Post-operative Analgesia in Children (1-6 Year) Undergoing Abdominal Surgeries Under General Anaesthesia.

Journal of pharmacy & bioallied sciences·2026
Same author

Retraction notice to "Bioactive compounds and their libraries: An insight into prospective phytotherapeutics approach for oral mucocutaneous cancers" [Biomedicine & Pharmacotherapy 141 (2021) 111809].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Related Experiment Video

Updated: Sep 29, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.1K

Solid Lipid Nanoparticles: Peculiar Strategy to Deliver Bio-Proactive Molecules.

Neha Minocha1,2, Nidhi Sharma3, Ravinder Verma1

  • 1Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak 124001, Haryana, India.

Recent Patents on Nanotechnology
|March 18, 2022
PubMed
Summary

Solid lipid nanoparticles (SLNs) offer superior drug delivery by enhancing solubility and bioavailability. These colloidal systems improve therapeutic effects for various drug types and administration routes.

Keywords:
Solid lipid nanoparticlesdrug carriersdrug targetingnanocarriersnanoformulationsnanotechnology

More Related Videos

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.1K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

24.2K

Related Experiment Videos

Last Updated: Sep 29, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.1K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.1K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

24.2K

Area of Science:

  • Pharmaceutical Sciences
  • Nanotechnology
  • Drug Delivery

Background:

  • Conventional drug delivery systems face limitations like poor solubility and low bioavailability.
  • These limitations necessitate advanced systems for improved drug efficacy.
  • Solid lipid nanoparticles (SLNs) emerge as a solution to overcome these challenges.

Purpose of the Study:

  • To explore the formulation and application of solid lipid nanoparticles (SLNs).
  • To enhance solubility and bioavailability of lipid or aqueous inclined drugs.
  • To achieve optimal therapeutic outcomes through advanced drug delivery.

Main Methods:

  • SLNs are colloidal carriers ranging from 50-1,000 nm.
  • They combine benefits of liposomes and emulsions for targeted delivery.
  • High absorption, stability, and drug packing improve pharmacokinetic and pharmacodynamic properties.

Main Results:

  • SLNs support diverse dosage forms and administration routes (oral, nasal, parenteral, etc.).
  • They exhibit enhanced physicochemical stability and cost-effective scalability.
  • Both lipophilic and hydrophilic drugs can be effectively encapsulated.

Conclusions:

  • This review covers SLN principles, mechanisms, patents, and applications.
  • SLNs represent a versatile platform for drug delivery.
  • They hold significant therapeutic potential across various medical fields.